{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:24:52Z","timestamp":1787066692250,"version":"build-2736575974"},"reference-count":98,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1053\/j.ajkd.2010.01.023","type":"journal-article","created":{"date-parts":[[2010,4,23]],"date-time":"2010-04-23T04:51:33Z","timestamp":1271998293000},"page":"359-370","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"title":["Emerging Role of the Bufadienolides in Cardiovascular and Kidney Diseases"],"prefix":"10.1053","volume":"56","author":[{"given":"Jules B.","family":"Puschett","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enoch","family":"Agunanne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad N.","family":"Uddin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.ajkd.2010.01.023_bib1","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1046\/j.1432-1033.2002.02911.x","article-title":"Endogenous cardiac glycosides, a new class of steroid hormones","volume":"269","author":"Schoner","year":"2002","journal-title":"Eur J Biochem."},{"key":"10.1053\/j.ajkd.2010.01.023_bib2","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.semnephrol.2005.03.010","article-title":"Endogenous cardiac glycosides: hormones using the sodium pump as signal transducer","volume":"25","author":"Schoner","year":"2005","journal-title":"Semin Nephrol."},{"key":"10.1053\/j.ajkd.2010.01.023_bib3","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1152\/ajpcell.00098.2007","article-title":"Endogenous and exogenous cardiac glycosides: their roles in hypertension, salt metabolism, and cell growth","volume":"293","author":"Schoner","year":"2007","journal-title":"Am J Physiol Cell Physiol."},{"issue":"6","key":"10.1053\/j.ajkd.2010.01.023_bib4","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1161\/01.HYP.17.6.944","article-title":"Effect of an endogenous ouabainlike compound on heart and aorta","volume":"17","author":"Bova","year":"1991","journal-title":"Hypertension"},{"key":"10.1053\/j.ajkd.2010.01.023_bib5","series-title":"Goodman and Gilman's Pharmacological Basis of Therapeutics","first-page":"901","article-title":"Pharmacological treatment of heart failure","author":"Ooi","year":"2001"},{"issue":"2","key":"10.1053\/j.ajkd.2010.01.023_bib6","first-page":"179","article-title":"Simultaneous quantification of seven major bufadienolides in three traditional Chinese medicinal preparations of Chan Su by HPLC-DAD","volume":"4","author":"Ma","year":"2009","journal-title":"Nat Prod Commun."},{"key":"10.1053\/j.ajkd.2010.01.023_bib7","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1161\/01.HYP.36.3.442","article-title":"Mammalian bufadienolide is synthesized from cholesterol in the adrenal cortex by a pathway that is independent of cholesterol side-chain cleavage","volume":"36","author":"Dmitrieva","year":"2000","journal-title":"Hypertension"},{"key":"10.1053\/j.ajkd.2010.01.023_bib8","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0140-6736(96)02257-X","article-title":"An inhibitor of the sodium pump obtained from human placenta","volume":"348","author":"Hilton","year":"1996","journal-title":"Lancet"},{"issue":"5","key":"10.1053\/j.ajkd.2010.01.023_bib9","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/ajh.2009.22","article-title":"Endogenous cardiotonic steroids and differential patterns of sodium pump inhibition in NaCl-loaded salt-sensitive and normotensive rats","volume":"22","author":"Bagrov","year":"2009","journal-title":"Am J Hypertens."},{"issue":"5","key":"10.1053\/j.ajkd.2010.01.023_bib10","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1159\/000088461","article-title":"Involvement of marinobufagenin in a rat model of human preeclampsia","volume":"25","author":"Vu","year":"2005","journal-title":"Am J Nephrol."},{"key":"10.1053\/j.ajkd.2010.01.023_bib11","doi-asserted-by":"crossref","first-page":"F633","DOI":"10.1152\/ajprenal.1998.275.5.F633","article-title":"Isozymes of the Na-K-ATPase: heterogeneity in structure, diversity in function","volume":"275","author":"Blanco","year":"1998","journal-title":"Am J Physiol Renal Physiol."},{"issue":"1","key":"10.1053\/j.ajkd.2010.01.023_bib12","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1124\/pr.108.000711","article-title":"Endogenous cardiotonic steroids physiology, pharmacology, and novel therapeutic targets","volume":"61","author":"Bagrov","year":"2009","journal-title":"Pharmacol Rev."},{"issue":"14","key":"10.1053\/j.ajkd.2010.01.023_bib13","doi-asserted-by":"crossref","first-page":"10585","DOI":"10.1074\/jbc.M609181200","article-title":"Identification of a pool of non-pumping Na\/K-ATPase","volume":"282","author":"Liang","year":"2007","journal-title":"J Biol Chem."},{"issue":"17","key":"10.1053\/j.ajkd.2010.01.023_bib14","doi-asserted-by":"crossref","first-page":"17250","DOI":"10.1074\/jbc.M313239200","article-title":"Ouabain assembles signaling cascades through the caveolar Na+\/K+-ATPase","volume":"23","author":"Wang","year":"2004","journal-title":"J Biol Chem."},{"key":"10.1053\/j.ajkd.2010.01.023_bib15","doi-asserted-by":"crossref","first-page":"6259","DOI":"10.1073\/pnas.88.14.6259","article-title":"Identification and characterization of a ouabain-like compound from human plasma","volume":"88","author":"Hamlyn","year":"1991","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.ajkd.2010.01.023_bib16","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1161\/01.HYP.17.6.923","article-title":"Purification of an endogenous digitalis like factor from human plasma for structural analysis","volume":"17","author":"Ludens","year":"1991","journal-title":"Hypertension"},{"key":"10.1053\/j.ajkd.2010.01.023_bib17","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/S0006-291X(05)80898-8","article-title":"Isolation of a urinary digitalis-like factor indistinguishable from digoxin","volume":"173","author":"Goto","year":"1990","journal-title":"Biochem Biophys Res Commun."},{"key":"10.1053\/j.ajkd.2010.01.023_bib18","doi-asserted-by":"crossref","first-page":"8189","DOI":"10.1073\/pnas.90.17.8189","article-title":"Physicochemical characterization of a ouabain isomer isolated from bovine hypothalamus","volume":"90","author":"Tymiak","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.ajkd.2010.01.023_bib19","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/00004872-200102000-00009","article-title":"Identification of endogenous ouabain in culture supernatant of PC12 cells","volume":"19","author":"Komiyama","year":"2001","journal-title":"J Hypertens."},{"issue":"1","key":"10.1053\/j.ajkd.2010.01.023_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0031-9422(97)00426-3","article-title":"Bufadienolides from animal and plant sources","volume":"48","author":"Krenn","year":"1998","journal-title":"Phytochemistry"},{"key":"10.1053\/j.ajkd.2010.01.023_bib21","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/j.1432-1033.1993.tb18141.x","article-title":"Identification of digitalis like compounds in human cataractous lenses","volume":"216","author":"Lichtstein","year":"1993","journal-title":"Eur J Biochem."},{"key":"10.1053\/j.ajkd.2010.01.023_bib22","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1097\/00004872-199816121-00015","article-title":"Effects of two putative endogenous digitalis-like factors, marinobufagenin and ouabain, on the Na+, K+-pump in human mesenteric arteries","volume":"16","author":"Bagrov","year":"1998","journal-title":"J Hypertens."},{"key":"10.1053\/j.ajkd.2010.01.023_bib23","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.clinbiochem.2004.08.005","article-title":"A novel endogenous digitalis, telocinobufagin, exhibits elevated plasma levels in patients with terminal renal failure","volume":"38","author":"Komiyama","year":"2005","journal-title":"Clin Biochem."},{"key":"10.1053\/j.ajkd.2010.01.023_bib24","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1097\/00004872-199917080-00018","article-title":"Circulating bufodienolide and cardenolide sodium pump inhibitors in preeclampsia","volume":"17","author":"Lopatin","year":"1999","journal-title":"J Hypertens."},{"key":"10.1053\/j.ajkd.2010.01.023_bib25","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1084\/jem.126.4.687","article-title":"Effects of chronic excess salt ingestion. Genetic influence on the development of salt hypertension in parabiotic rats. Evidence for a circulating factor","volume":"126","author":"Dahl","year":"1967","journal-title":"J Exp Med."},{"key":"10.1053\/j.ajkd.2010.01.023_bib26","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1152\/physrev.1985.65.3.658","article-title":"Concept of natriuretic hormone","volume":"65","author":"deWardener","year":"1985","journal-title":"Physiol Rev."},{"key":"10.1053\/j.ajkd.2010.01.023_bib27","doi-asserted-by":"crossref","first-page":"C167","DOI":"10.1152\/ajpcell.1977.232.5.C165","article-title":"Sodium ions, calcium ions, blood pressure regulation and hypertension","volume":"232","author":"Blaustein","year":"1977","journal-title":"Am J Physiol."},{"key":"10.1053\/j.ajkd.2010.01.023_bib28","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/300650a0","article-title":"A circulating inhibitor of (Na+K)-ATPase associated with essential hypertension","volume":"300","author":"Hamlyn","year":"1982","journal-title":"Nature"},{"key":"10.1053\/j.ajkd.2010.01.023_bib29","doi-asserted-by":"crossref","first-page":"C1367","DOI":"10.1152\/ajpcell.1993.264.6.C1367","article-title":"Physiological effects of endogenous ouabain","volume":"264","author":"Blaustein","year":"1993","journal-title":"Am J Physiol."},{"key":"10.1053\/j.ajkd.2010.01.023_bib30","series-title":"Textbook of Medical Physiology","first-page":"206","article-title":"Physics of blood, blood flow, and pressure: hemodynamics","author":"Guyton","year":"1986"},{"key":"10.1053\/j.ajkd.2010.01.023_bib31","first-page":"2415","article-title":"The vasoconstriction-volume spectrum in normotension and in the pathogenesis of hypertension","volume":"41","author":"Laragh","year":"1982","journal-title":"Fed Proc."},{"issue":"2","key":"10.1053\/j.ajkd.2010.01.023_bib32","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1001\/jama.1979.03290280031022","article-title":"Renin profiling for diagnosis and treatment of hypertension","volume":"241","author":"Laragh","year":"1979","journal-title":"JAMA"},{"issue":"1","key":"10.1053\/j.ajkd.2010.01.023_bib33","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1161\/HYPERTENSIONAHA.109.133785","article-title":"Enhanced distal nephron sodium reabsorption in chronic angiotensin II-infused mice","volume":"54","author":"Zhao","year":"2009","journal-title":"Hypertension"},{"key":"10.1053\/j.ajkd.2010.01.023_bib34","doi-asserted-by":"crossref","first-page":"F319","DOI":"10.1152\/ajprenal.2000.279.2.F319","article-title":"Impairment of pressure-natriuresis and renal authoregulation in ANG II-infused hypertensive rats","volume":"279","author":"Wang","year":"2000","journal-title":"Am J Physiol Renal Physiol."},{"key":"10.1053\/j.ajkd.2010.01.023_bib35","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/01.hco.0000127136.50978.db","article-title":"Sodium and blood pressure 2003","volume":"19","author":"Weinberger","year":"2004","journal-title":"Curr Opin Cardiol."},{"key":"10.1053\/j.ajkd.2010.01.023_bib36","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1152\/physrev.00056.2003","article-title":"Links between dietary salt intake, renal salt handling, blood pressure, and cardiovascular diseases","volume":"85","author":"Meneton","year":"2005","journal-title":"Physiol Rev."},{"issue":"2","key":"10.1053\/j.ajkd.2010.01.023_bib37","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1161\/01.HYP.37.2.462","article-title":"Marinobufagenin, an endogenous \u03b1-1 sodium pump ligand, in hypertensive Dahl salt-sensitive rats","volume":"37","author":"Fedorova","year":"2001","journal-title":"Hypertension"},{"key":"10.1053\/j.ajkd.2010.01.023_bib38","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1097\/01.hjh.0000163153.27954.33","article-title":"Antibody to marinobufagenin lowers blood pressure in pregnant rats on a high NaCl intake","volume":"23","author":"Fedorova","year":"2005","journal-title":"J Hypertens."},{"key":"10.1053\/j.ajkd.2010.01.023_bib39","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1161\/hc0902.104710","article-title":"Endogenous ligand of \u03b11 sodium pump, marinobufagenin, is a novel mediator of sodium chloride-dependent hypertension","volume":"105","author":"Fedorova","year":"2002","journal-title":"Circulation"},{"key":"10.1053\/j.ajkd.2010.01.023_bib40","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1161\/01.HYP.18.3.316","article-title":"Effects of three sodium-potassium adenosine triphosphatase inhibitors","volume":"18","author":"Pamnani","year":"1991","journal-title":"Hypertension"},{"issue":"suppl I","key":"10.1053\/j.ajkd.2010.01.023_bib41","first-page":"I-106","article-title":"Chronic blood pressure effects of bufalin, a sodium-potassium ATPase inhibitor, in rats","volume":"23","author":"Pamnani","year":"1994","journal-title":"Hypertension"},{"issue":"3","key":"10.1053\/j.ajkd.2010.01.023_bib42","first-page":"210","article-title":"Hypertension and a digoxin-like marker in the plasma of dialysis patients: possible marker for a natriuretic hormone","volume":"4","author":"Ahmad","year":"1986","journal-title":"Clin Physiol Biochem."},{"issue":"9075","key":"10.1053\/j.ajkd.2010.01.023_bib43","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0140-6736(97)24032-8","article-title":"Evidence for circulating bufenolide in a volume-expanded patient","volume":"350","author":"Wright","year":"1997","journal-title":"Lancet"},{"issue":"5&6","key":"10.1053\/j.ajkd.2010.01.023_bib44","doi-asserted-by":"crossref","first-page":"617","DOI":"10.3109\/10641969809053240","article-title":"Simultaneous measurement of marinobufagenin, ouabain, and hypertension-associated protein in various disease states","volume":"20","author":"Gonick","year":"1998","journal-title":"Clin Exp Hypertens."},{"issue":"8","key":"10.1053\/j.ajkd.2010.01.023_bib45","first-page":"19","article-title":"Endogenous Na\/K-ATPase inhibitors in patients with preeclampsia","volume":"52","author":"Averina","year":"2006","journal-title":"Cell Mol Biol."},{"key":"10.1053\/j.ajkd.2010.01.023_bib46","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1097\/00004872-200206000-00032","article-title":"Marinobufagenin, an endogenous ligand of alpha-1 sodium pump, is a marker of congestive heart failure severity","volume":"20","author":"Fridman","year":"2002","journal-title":"J Hypertens."},{"key":"10.1053\/j.ajkd.2010.01.023_bib47","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1177\/153537020623100212","article-title":"Resibufogenin corrects hypertension in a rat model of human preeclampsia","volume":"231","author":"Vu","year":"2006","journal-title":"Exp Biol Med."},{"issue":"1","key":"10.1053\/j.ajkd.2010.01.023_bib48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/10641950802629709","article-title":"Resibufogenin prevents the manifestations of preeclampsia in an animal model of the syndrome","volume":"29","author":"Horvat","year":"2010","journal-title":"Hypertens Pregnancy"},{"key":"10.1053\/j.ajkd.2010.01.023_bib49","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000108756","article-title":"Effects of resibufogenin in experimental hypertension","volume":"28","author":"Danchuk","year":"2008","journal-title":"Am J Nephrol."},{"key":"10.1053\/j.ajkd.2010.01.023_bib50","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1097\/HJH.0b013e328312c86a","article-title":"Monoclonal antibody to an endogenous bufadienolide, marinobufagenin, reverses preeclampsia-induced Na\/K-ATPase inhibition and lowers blood pressure in NaCl-sensitive hypertension","volume":"26","author":"Fedorova","year":"2008","journal-title":"J Hypertens."},{"key":"10.1053\/j.ajkd.2010.01.023_bib51","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1097\/00006254-200209000-00023","article-title":"Preeclampsia, part I: clinical and pathophysiological considerations","volume":"57","author":"Pridjian","year":"2002","journal-title":"Obstet Gynecol Surv."},{"key":"10.1053\/j.ajkd.2010.01.023_bib52","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1097\/00006254-200209000-00024","article-title":"Preeclampsia, part II: experimental and genetic considerations","volume":"57","author":"Pridjian","year":"2002","journal-title":"Obstet Gynecol Surv."},{"key":"10.1053\/j.ajkd.2010.01.023_bib53","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/0002-9378(89)90665-0","article-title":"Preeclampsia: an endothelial cell disorder","volume":"161","author":"Roberts","year":"1989","journal-title":"Am J Obstet Gynecol."},{"key":"10.1053\/j.ajkd.2010.01.023_bib54","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/j.mehy.2006.04.059","article-title":"The role of excessive volume expansion in the pathogenesis of preeclampsia","volume":"67","author":"Puschett","year":"2006","journal-title":"Med Hypotheses"},{"key":"10.1053\/j.ajkd.2010.01.023_bib55","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.2741\/2241","article-title":"Angiogenic factors in preeclampsia","volume":"12","author":"Tjoa","year":"2007","journal-title":"Front Biosci."},{"issue":"7","key":"10.1053\/j.ajkd.2010.01.023_bib56","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1172\/JCI4106","article-title":"Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor","volume":"103","author":"Wallukat","year":"1999","journal-title":"J Clin Invest."},{"key":"10.1053\/j.ajkd.2010.01.023_bib57","first-page":"219","article-title":"Anemia in pregnancy","volume":"1","author":"Scott","year":"1972","journal-title":"Obstet Gynecol Annu."},{"key":"10.1053\/j.ajkd.2010.01.023_bib58","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1080\/10641960500298608","article-title":"A rat model of preeclampsia","volume":"8","author":"Ianosi-Irimie","year":"2005","journal-title":"Clin Exp Hypertens."},{"key":"10.1053\/j.ajkd.2010.01.023_bib59","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1469-7580.2008.01039.x","article-title":"Trophoblast-mediated spiral artery remodeling: a role for apoptosis","volume":"215","author":"Whitley","year":"2009","journal-title":"J Anat."},{"key":"10.1053\/j.ajkd.2010.01.023_bib60","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.placenta.2005.12.004","article-title":"Marinobufagenin impairs first trimester cytotrophoblast differentiation","volume":"27","author":"Lamarca","year":"2006","journal-title":"Placenta"},{"key":"10.1053\/j.ajkd.2010.01.023_bib61","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.placenta.2007.12.009","article-title":"Marinobufagenin inhibits proliferation and migration of cytotrophoblast and CHO cells","volume":"29","author":"Uddin","year":"2008","journal-title":"Placenta"},{"issue":"19","key":"10.1053\/j.ajkd.2010.01.023_bib62","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1056\/NEJMra000763","article-title":"Implantation and the survival of early pregnancy","volume":"345","author":"Nortwitz","year":"2001","journal-title":"N Engl J Med."},{"key":"10.1053\/j.ajkd.2010.01.023_bib63","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0143-4004(80)80012-9","article-title":"Trophoblastic invasion of human decidua from 8 to 18 weeks of pregnancy","volume":"1","author":"Pijnenbort","year":"1980","journal-title":"Placenta"},{"issue":"4","key":"10.1053\/j.ajkd.2010.01.023_bib64","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1055\/s-0029-1241739","article-title":"The treatment of preeclampsia in a rat model employing Digibind.\u00ae","volume":"27","author":"Agunanne","year":"2010","journal-title":"Am J Perinatol."},{"issue":"2","key":"10.1053\/j.ajkd.2010.01.023_bib65","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1172\/JCI101945","article-title":"Plasma volume, total circulating protein, and \u201cavailable fluid\u201d abnormalities in preeclampsia and eclampsia","volume":"27","author":"Freis","year":"1948","journal-title":"J Clin Invest."},{"issue":"12","key":"10.1053\/j.ajkd.2010.01.023_bib66","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1001\/jama.1967.03120120085014","article-title":"Iron deficiency in healthy young college women","volume":"199","author":"Scott","year":"1967","journal-title":"JAMA"},{"key":"10.1053\/j.ajkd.2010.01.023_bib67","first-page":"163","article-title":"Evans blue disappearance rate in normal and preeclamptic pregnancy","volume":"2","author":"Campbell","year":"1983","journal-title":"Clin Exp Hypertens."},{"key":"10.1053\/j.ajkd.2010.01.023_bib68","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/107155769900600103","article-title":"Preeclampsia: the endothelium, circulating factor(s) and vascular endothelial growth factor","volume":"6","author":"Hayman","year":"1999","journal-title":"J Soc Gynecol Invest."},{"issue":"1","key":"10.1053\/j.ajkd.2010.01.023_bib69","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1159\/000193220","article-title":"Vascular leak in a rat model of preeclampsia","volume":"30","author":"Uddin","year":"2009","journal-title":"Am J Nephrol."},{"issue":"6","key":"10.1053\/j.ajkd.2010.01.023_bib70","doi-asserted-by":"crossref","first-page":"R1726","DOI":"10.1152\/ajpregu.90963.2008","article-title":"Marinobufagenin causes endothelial cell monolayer hyperpermeability by altering apoptotic signaling","volume":"296","author":"Uddin","year":"2009","journal-title":"Am J Physiol Regul Integr Comp Physiol."},{"issue":"2","key":"10.1053\/j.ajkd.2010.01.023_bib71","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0002-9378(88)80071-1","article-title":"Sodium excretion in normal and hypertensive pregnancy: a prospective study","volume":"159","author":"Brown","year":"1988","journal-title":"Am J Obstet Gynecol."},{"issue":"2","key":"10.1053\/j.ajkd.2010.01.023_bib72","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/00003081-195806000-00003","article-title":"The renal excretion of sodium in women with preeclampsia","volume":"1","author":"Chesley","year":"1958","journal-title":"Clin Obstet Gynecol."},{"issue":"5","key":"10.1053\/j.ajkd.2010.01.023_bib73","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1172\/JCI17189","article-title":"Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia","volume":"111","author":"Maynard","year":"2003","journal-title":"J Clin Invest."},{"key":"10.1053\/j.ajkd.2010.01.023_bib74","series-title":"Williams Obstetrics","first-page":"761","article-title":"Hypertensive disorders in pregnancy","author":"Cunningham","year":"2005"},{"issue":"5","key":"10.1053\/j.ajkd.2010.01.023_bib75","first-page":"575","article-title":"Excretion of sodium loads by nonpregnant and pregnant normal, hypertensive and pre-eclamptic women","volume":"VII","author":"Chesley","year":"1958","journal-title":"Metabolism"},{"key":"10.1053\/j.ajkd.2010.01.023_bib76","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/0002-9378(80)90078-2","article-title":"Hormone production during pregnancy in the primigravid patient","volume":"138","author":"Parker","year":"1980","journal-title":"Am J Obstet Gynecol."},{"issue":"26","key":"10.1053\/j.ajkd.2010.01.023_bib77","doi-asserted-by":"crossref","first-page":"17946","DOI":"10.1074\/jbc.M800958200","article-title":"Examination of the cellular mechanisms by which marinobufagenin inhibits cytotrophoblast function","volume":"283","author":"Uddin","year":"2008","journal-title":"J Biol Chem."},{"key":"10.1053\/j.ajkd.2010.01.023_bib78","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jri.2005.10.007","article-title":"Cytokine mapping of sera from women with preeclampsia and normal pregnancies","volume":"70","author":"Johnson","year":"2006","journal-title":"J Reprod Immunol."},{"issue":"10","key":"10.1053\/j.ajkd.2010.01.023_bib79","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1038\/ajh.2009.125","article-title":"Immunosuppression improves blood pressure and endothelial function in a rat model of pregnancy-induced hypertension","volume":"22","author":"Tinsley","year":"2009","journal-title":"Am J Hypertens."},{"key":"10.1053\/j.ajkd.2010.01.023_bib80","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1021\/np049950e","article-title":"Inhibitory effects of bufadienolides on interleukin-6 in MH-60 cells","volume":"67","author":"Enomoto","year":"2004","journal-title":"J Nat Prod."},{"key":"10.1053\/j.ajkd.2010.01.023_bib81","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1124\/jpet.102.036137","article-title":"Biological activity of a novel nonpeptide antagonist to the interleukin-6 receptor 20S, 21-epoxy-resibufogenin-3-formate","volume":"303","author":"Hayashi","year":"2002","journal-title":"J Pharmacol Exp Ther."},{"key":"10.1053\/j.ajkd.2010.01.023_bib82","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/j.bbrc.2004.08.196","article-title":"Suppression of cancer cachexia by 20S, 21-epoxy-resibufogenin-3-acetate\u2014a novel nonpeptide IL-6 receptor antagonist","volume":"323","author":"Enomoto","year":"2004","journal-title":"Biochem Biophys Res Commun."},{"key":"10.1053\/j.ajkd.2010.01.023_bib83","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0162-3109(00)00264-2","article-title":"The T-cell suppressive effect of bufadienolides: structural requirements for their immunoregulatory activity","volume":"1","author":"Terness","year":"2001","journal-title":"Int Immunopharmacol."},{"key":"10.1053\/j.ajkd.2010.01.023_bib84","doi-asserted-by":"crossref","first-page":"R529","DOI":"10.1152\/ajpregu.00518.2005","article-title":"Rostafuroxin: an ouabain antagonist that corrects renal and vascular Na+-K+-ATPase alterations in ouabain and adducin-dependent hypertension","volume":"290","author":"Ferrari","year":"2006","journal-title":"Am J Physiol Regul Integr Comp Physiol."},{"key":"10.1053\/j.ajkd.2010.01.023_bib85","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1161\/01.CIR.0000095676.90936.80","article-title":"Kidney disease as a risk factor for development of cardiovascular disease","volume":"108","author":"Sarnak","year":"2003","journal-title":"Circulation"},{"key":"10.1053\/j.ajkd.2010.01.023_bib86","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1111\/j.1523-1755.2002.kid571.x","article-title":"Mild renal insufficiency is associated with increased cardiovascular mortality: the Hoorn Study","volume":"62","author":"Henry","year":"2002","journal-title":"Kidney Int."},{"issue":"suppl 1","key":"10.1053\/j.ajkd.2010.01.023_bib87","first-page":"S137","article-title":"Excerpts from the US Renal Data System, 2007 Annual Data Report, Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States","volume":"51","year":"2008","journal-title":"Am J Kidney Dis."},{"key":"10.1053\/j.ajkd.2010.01.023_bib88","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1046\/j.1523-1755.2003.00914.x","article-title":"Effect of green tea extract on cardiac hypertrophy following 5\/6 nephrectomy in the rat","volume":"63","author":"Priyadarshi","year":"2003","journal-title":"Kidney Int."},{"key":"10.1053\/j.ajkd.2010.01.023_bib89","doi-asserted-by":"crossref","first-page":"F450","DOI":"10.1152\/ajprenal.00472.2007","article-title":"Partial nephrectomy as a model for uremic cardiomyopathy in the mouse","volume":"294","author":"Kennedy","year":"2008","journal-title":"Am J Physiol Renal Physiol."},{"key":"10.1053\/j.ajkd.2010.01.023_bib90","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1161\/01.HYP.0000202594.82271.92","article-title":"Central role for the cardiotonic steroid marinobufagenin in the pathogenesis of experimental uremic cardiomyopathy","volume":"47","author":"Kennedy","year":"2006","journal-title":"Hypertension"},{"key":"10.1053\/j.ajkd.2010.01.023_bib91","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1161\/01.HYP.0000252409.36927.05","article-title":"Marinobufagenin stimulates fibroblast collagen production and causes fibrosis in experimental uremic cardiomyopathy","volume":"49","author":"Elkareh","year":"2007","journal-title":"Hypertension"},{"key":"10.1053\/j.ajkd.2010.01.023_bib92","doi-asserted-by":"crossref","first-page":"F1219","DOI":"10.1152\/ajprenal.90710.2008","article-title":"Marinobufagenin induces increases in procollagen expression in a process involving protein kinase C and Fli-1: implications for uremic cardiomyopathy","volume":"296","author":"Elkareh","year":"2009","journal-title":"Am J Physiol Renal Physiol."},{"key":"10.1053\/j.ajkd.2010.01.023_bib93","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1161\/HYPERTENSIONAHA.109.140038","article-title":"Spironolactone attenuates experimental uremic cardiomyopathy by antagonizing marinobufagenin","volume":"54","author":"Tian","year":"2009","journal-title":"Hypertension"},{"key":"10.1053\/j.ajkd.2010.01.023_bib94","doi-asserted-by":"crossref","first-page":"F922","DOI":"10.1152\/ajprenal.90605.2008","article-title":"The cardiotonic steroid hormone marinobufagenin induces renal fibrosis: implication of epithelial-to-mesenchymal transition","volume":"296","author":"Fedorova","year":"2009","journal-title":"Am J Physiol Renal Physiol."},{"key":"10.1053\/j.ajkd.2010.01.023_bib95","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1007\/s004670000461","article-title":"Molecular basis of renal fibrosis","volume":"15","author":"Eddy","year":"2000","journal-title":"Pediatr Nephrol."},{"key":"10.1053\/j.ajkd.2010.01.023_bib96","doi-asserted-by":"crossref","first-page":"467","DOI":"10.2174\/1566524054553478","article-title":"Cellular and molecular pathways that lead to progression and regression of renal fibrogenesis","volume":"5","author":"Okada","year":"2005","journal-title":"Curr Mol Med."},{"key":"10.1053\/j.ajkd.2010.01.023_bib97","doi-asserted-by":"crossref","first-page":"6991","DOI":"10.2741\/3204","article-title":"Fibroblasts emerge via epithelial-mesenchymal transition in chronic kidney fibrosis","volume":"13","author":"Zeisberg","year":"2008","journal-title":"Front Biosci."},{"issue":"2","key":"10.1053\/j.ajkd.2010.01.023_bib98","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1083\/jcb.130.2.393","article-title":"Identification and characterization of a fibroblast marker: FSP1","volume":"130","author":"Strutz","year":"1995","journal-title":"J Cell Biol."}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638610005603?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638610005603?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T01:55:17Z","timestamp":1759456517000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638610005603"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8]]},"references-count":98,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["S0272638610005603"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2010.01.023","relation":{},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2010,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Emerging Role of the Bufadienolides in Cardiovascular and Kidney Diseases","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2010.01.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}